On June 16, 2026, Aimed Alliance released its latest publication, Guardrails for Care: AI and the Future of Patient Protection,…
The Food and Drug Administration’s (FDA) integration of artificial intelligence (AI) into drug development and manufacturing is expanding rapidly, but…
A recent Office of Inspector General (OIG) report investigating the impact of vertical integration in Medicare Part D highlights significant…
On May 19, Governor Spanberger vetoed H.B.483/S.B.271, which would have established a Prescription Drug Affordability Board (PDAB) in Virginia. Aimed…
On May 1, 2026, Pennsylvania filed a lawsuit against Character.ai, a generative artificial intelligence (AI) system that allow users to…
On March 23, 2026, the FTC and CVS Caremark jointly moved to withdraw from the administrative proceeding to allow the…
Aimed Alliance has released two new resources, one for consumers and one for employers, examining the growing use of alternative…
Aimed Alliance has released a new resource explaining recent federal reforms to pharmacy benefit managers (PBMs) under the Consolidated Appropriations…
On May 11, Aimed Alliance sent a letter urging opposition to Louisiana S.B. 401, which would establish a Prescription Drug…
On May 11, Aimed Alliance sent a letter expressing support for H.R. 8270, the Every Dollar Counts Act, which would…